Robin Shaw
Co-Founder

TIKKUNLEV Therapeutics develops precision medicine programs focused on cardiovascular disease. The company's primary goal is to repair failing heart muscle at the biological level. This approach aims to reverse the progression of heart failure in patients.
Co-Founder